Home > Cashflow Statement > CONCORD DRUGS

CONCORD DRUGS
Cash Flow from Financing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for CONCORD DRUGS
Please provide your vote to see the results

CONCORD DRUGS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-1.43 Cr₹0.28 Cr₹0.62 Cr₹1.68 Cr

What is the latest Cash Flow from Financing Activities ratio of CONCORD DRUGS ?

The latest Cash Flow from Financing Activities ratio of CONCORD DRUGS is ₹-1.43 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-1.43 Cr
Mar2024₹0.28 Cr
Mar2023₹0.62 Cr
Mar2022₹1.68 Cr

How is Cash Flow from Financing Activities of CONCORD DRUGS Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-1.43 Cr
Negative
Mar2024 ₹0.28 Cr
-54.65
Mar2023 ₹0.62 Cr
-62.84
Mar2022 ₹1.68 Cr -

Compare Cash Flow from Financing Activities of peers of CONCORD DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD DRUGS ₹93.7 Cr -2.4% -1% -16.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,944.0 Cr -2% 6% 9.6% Stock Analytics
DIVIS LABORATORIES ₹294,962.0 Cr -4% 22.9% 75.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹178,391.0 Cr -1.8% 1.8% 21.9% Stock Analytics
DR REDDYS LABORATORIES ₹115,267.0 Cr -0.4% 13.1% 13.7% Stock Analytics
CIPLA ₹112,620.0 Cr -0.9% 4.5% -8% Stock Analytics


CONCORD DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD DRUGS

-2.4%

-1%

-16.2%

SENSEX

1.4%

12.8%

-1.7%


You may also like the below Video Courses